TIME-VARYING EFFECTS OF HEALTH-SEEKING DELAYS ON PROSTATE CANCER MORTALITY IN KENYA A SURVIVAL ANALYSIS APPROACH
Main Article Content
Abstract
Prostate cancer is frequently diagnosed at advanced stages in Kenya, contributing to poor survival outcomes. Health-seeking delays across the care continuum are thought to influence mortality, but most research has treated delay as a static baseline factor, obscuring how its effect may change over time. This study investigated the time-varying effects of delays on prostate cancer mortality in Kenya using a retrospective cohort of 420 patients from the National Cancer Registry of Kenya. Cox proportional hazards models with time-dependent covariates and landmark analysis at 3, 6, and 12 months post-diagnosis were applied. Of the 420 patients, 230 (54.8%) died during follow-up, with an overall median survival of 33.8 months. Total delay was independently associated with mortality hazard in both baseline (HR = 1.04, p = 0.006) and time-varying (HR = 1.04, p = 0.007) Cox models, alongside age, disease stage, and Gleason score. Landmark analysis showed that total delay remained a significant predictor of subsequent survival at 3, 6, and 12 months (p = 0.041, 0.035, and 0.039, respectively), while treatment interruption reached significance specifically at 6 months (p = 0.034), suggesting a critical prognostic window approximately three to six months after diagnosis. The delay-informed predictive model achieved an optimism-corrected concordance index of 0.723 and a mean time-dependent AUC of 0.787. These findings establish total delay as a robust, time-varying predictor of prostate cancer mortality in this Kenyan cohort and identify the three-to-six-month post-diagnosis window as a priority target for clinical monitoring and patient re-engagement interventions.
Article Details
References
Anderson, J. R., Cain, K. C., & Gelber, R. D. (2015). Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables. Journal of Clinical Oncology, 33(15), 1693-1698.
Austin, P. C., Lee, D. S., & Fine, J. P. (2020). Introduction to the analysis of survival data in the presence of competing risks. Circulation, 133(6), 601-609.
Ayele, G. M., Zewotir, T., & Mwambi, H. (2021). Landmark analysis of cervical cancer outcomes in Ethiopia. BMC Cancer, 21(1), 1-12.
Badu-Peprah, A., Adu-Sarkodie, Y., & Ofori-Atta, A. (2018). Delays in diagnosis and treatment of prostate cancer in Ghana. Ghana Medical Journal, 52(2), 67-73.
Crowther, M. J., Abrams, K. R., & Lambert, P. C. (2019). Flexible parametric joint modelling of longitudinal and survival data. Statistics in Medicine, 31(30), 4456-4471.
Fisher, L. D., & Lin, D. Y. (1999). Time-dependent covariates in the Cox proportional-hazards regression model. Annual Review of Public Health, 20(1), 145-157.
Korir, A., Okerosi, N., Ronoh, V., Mutuma, G., & Parkin, M. (2020). Cancer incidence and mortality trends in Kenya: 2010-2019. Journal of Global Oncology, 6, 1-10.
Makau-Barasa, L. K., Greene, S. B., Othieno-Abinya, N. A., Wheeler, S., Skinner, A., & Bennett, A. V. (2021). Improving access to cancer testing and treatment in Kenya. Journal of Global Oncology, 4, 1-8.
Mutua, M. K., Wabinga, H., Mwaka, A. D., & Mwanda, W. O. (2022). Barriers to timely diagnosis and treatment of prostate cancer in Kenya: A qualitative study. BMC Cancer, 22(1), 45.
Mwangi, P. W., Wanjala, R., & Nduati, R. (2023). Time-dependent effects of treatment interruptions on HIV mortality in Kenya. AIDS Research and Therapy, 20(1), 1-10.
Neal, R. D., Tharmanathan, P., France, B., Din, N. U., Cotton, S., Fallon-Ferguson, J., ... & Emery, J. (2015). Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. British Journal of Cancer, 112(1), S92-S107.
Neal, R. D., Nekhlyudov, L., & Smith, S. M. (2020). Methodological approaches to measuring delay-outcome relationships in cancer research. BMC Medical Research Methodology, 20(1), 1-15.
Ngugi, C. W., Mwangi, J. K., & Omondi, P. (2018). Diagnostic delay and metastatic disease at presentation in Kenyan prostate cancer patients. East African Medical Journal, 95(6), 1562-1570.
Ogutu, D. J., Omondi, P., & Mwangi, J. K. (2021). Geographical access to cancer care in Kenya. Pan African Medical Journal, 40, 1-10.
Owenga, J. A., & Nyambedha, E. O. (2018). Traditional healing and biomedical care pathways in Western Kenya. Journal of Ethnobiology and Ethnomedicine, 14(1), 1-12.
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995). Importance of events per independent variable in proportional hazards regression analysis II: Accuracy and precision of regression estimates. Journal of Clinical Epidemiology, 48(12), 1503-1510.
Scott, S. E., Walter, F. M., Webster, A., Sutton, S., & Emery, J. (2013). The model of pathways to treatment: Conceptualization and integration with existing theory. British Journal of Health Psychology, 18(1), 45-65.
Therneau, T. M., & Grambsch, P. M. (2000). Modeling Survival Data: Extending the Cox Model. Springer.
Van Houwelingen, H. C. (2007). Dynamic prediction by landmarking in event history analysis. Scandinavian Journal of Statistics, 34(1), 70-85.
Xiao, C., Zhong, L., & Wang, Z. (2019). Treatment delays and biochemical recurrence in localized prostate cancer: A meta-analysis. Prostate Cancer and Prostatic Diseases, 22(4), 536-545